Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 1,794

Document Document Title
WO/2012/122349A1
The present invention discloses catalyst compositions employing transition metal complexes with a thiolate ligand. Methods for making these transition metal complexes and for using such compounds in catalyst compositions for the polymeri...  
WO/2012/111380A1
The molecular structure of a metal salen complex erxhibiting a pharmacological effect has been clarified, and provided are a metal salen complex provided with such a molecular structure, as well as a derivative of the complex. A metal sa...  
WO/2012/110063A1
A process for preparing amino acid chelate compounds, characterized in that metal oxides and/or metal carbonates and/or metal sulfates and/or metal chlorides and/or metal hydroxides are mechanically activated in solid form and then the a...  
WO/2012/106694A2
A novel class of lanthanide metal phenoxyimine complexes can be used as an ingredient of a catalyst system. The catalyst system can be used in polymerizations of ethylenically unsaturated hydrocarbon monomers.  
WO/2012/106697A2
A novel class of lanthanide metal salen complexes can be used as an ingredient of a catalyst system. The catalyst system can be used in polymerizations of ethylenically unsaturated hydrocarbon monomers.  
WO/2012/106695A2
A novel class of aminidate complexes can be used as an ingredient of a catalyst system. The catalyst system can be used in polymerizations of ethylenically unsaturated hydrocarbon monomers.  
WO/2012/099707A2
Ul3(1,4-dioxane)1.5 and Ul4(1,4-dioxane)2, were synthesized in high yield by reacting turnings of elemental uranium with iodine dissolved in 1,4-dioxane under mild conditions. These molecular compounds of uranium are thermally stable and...  
WO/2012/060428A1
Disclosed is an (amide amino alkane) metal compound represented in general formula 1, and a method of manufacturing the metal-containing thin film using said metal compound. (In the formula, M represents a metal atom, R1 represents a lin...  
WO/2012/048815A1
The invention relates to a method for producing metal complexes of formula (2) [MaLxXn]Ym (2), where M is a metal from the group consisting of Mn(ll), Mn(lll), Mn(IV), Fe(ll), Fe(lll) or Fe(IV), X is a coordinating compound selected from...  
WO/2012/017869A1
[Problem] To provide a metal complex dye, a photoelectric conversion element and a photoelectrochemical cell with a high conversion efficiency and excellent durability. [Solution] A metal complex dye comprising a ligand LL1 represented b...  
WO/2012/017103A1
The invention relates to novel compounds such as succinimidyl ester of the Zn(ll) dithiocarbamate of isonipecotic acid and succinimidyl ester of Zn(ll) of dithiocarbamate of nipecotic acid; to the methods for preparing same, causing any ...  
WO/2011/157716A1
The present invention relates to new peptides, pharmaceutical composition and cosmetic composition comprising them and their use for wound healing.  
WO/2011/151399A1
The present invention is directed to a rhenium complex of general Formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein X is Se; Y is NH, O or S or is a methylene group; Z is halogen; m = 0, 1, or 2 and p = 0, 1, ...  
WO/2011/133115A1
The present invention relates to a radiolabelling imaging agent comprising ornithine and derivatives thereof modified to incorporate a Technetium (99n,Tc) radiolabel. The radioiabelled imaging agents are substrates for Ornithine Decarbox...  
WO/2011/066935A3
The invention relates to compounds in solid form, containing a) one or more manganese complex compounds of the general formula (1), where M is independently selected from manganese in the III or IV oxidation state, X is independently a c...  
WO/2011/110315A1
The present invention relates to new rhenium compounds of formula (I) with medical utility, corresponding pharmaceutical compositions as well as medical uses thereof.  
WO/2011/106906A1
The present invention concerns synthesising manganese complexes in essentially non-aqueous solutions.  
WO/2011/095307A1
The invention relates to a method for producing homogeneous solutions of metal complexes of general formula (2): [MaLxXn]Ym , where M is a metal from the group comprising Mn(II), Mn(III), Mn(IV), Fe(II), Fe(III) or Fe(IV), X is a coordin...  
WO/2011/095308A1
The invention describes a process for producing metal complexes of the general formula (2): [MaLxXn]Ym (2), where M is a metal from the group comprising Mn(II), Mn(III), Mn(IV), Fe(II), Fe(III) or Fe(IV), X is a coordinated compound sele...  
WO/2011/075618A1
This invention relates to a method for characterizing the pores of reticulated framework structures and using these characteristics to predict the actual performance characteristics of the reticulated framework structures as membranes fo...  
WO/2011/066935A2
The invention relates to compounds in solid form, containing a) one or more manganese complex compounds of the general formula (1), where M is independently selected from manganese in the III or IV oxidation state, X is independently a c...  
WO/2011/058277A1
The present invention relates to novel spin-transition materials, doped with a fluorescent agent, as well as to a method for preparing same, and to a method for detecting temperature changes by means of said materials.  
WO/2010/065906A3
A compound that recognizes and binds to the CA-IX protein has Formula I, II, III, or IV. The compounds may include a radioactive element for radioimaging or therapeutic applications. Thus, pharmaceutical compositions may be prepared with...  
WO/2011/052805A1
To provide nitrogen-containing aromatic compounds with excellent oxygen reduction activity, metal complexes containing them, and catalysts and electrodes employing the same, the present invention provides an aromatic compound satisfying ...  
WO/2011/032666A1
The invention relates to a method for producing manganese complex compounds of the general formula (1), wherein M, X, L, z, Y and q are defined as in claim 1. The method is characterized by the following steps: a) reacting one or more bi...  
WO/2011/034183A1
Disclosed is a novel porphyrin metal complex which is safe in vivo and satisfies requirements for relaxation ability, cancer cell selectivity, organ selectivity and the like. The porphyrin metal complex is able to be applied to an MRI co...  
WO/2010/028780A3
The invention relates to porphyrins, porphyrazines and phthalocyanines carrying a guanidine substituent. These compounds are obtained by treating a porphyrin, porphyrazine or phthalocyanine, respectively, carrying an amino substituent wi...  
WO/2010/043218A3
The invention relates to a ligand of formula (I), where (CH-R1) and (CH-R1') are substituted or non-substituted methylene bridges; the individual R1 and R1', and R3 and R3', are each selected independently of each other from hydrogen, su...  
WO/2011/008132A1
Claimed are a compound of the general formula (I) and pharmaceutically acceptable salts thereof, where M signifies metal atoms selected independently from the group comprising Pd, Fe, Mn, Co, Ni, Cu, Zn and Mo; R1 and R2, independently o...  
WO/2009/112823A8
A method for synthesizing a complex having the formula: [L3MO3]" wherein L3 represents a tridentate ligand, M represents a metal selected from Tc an Re, and n is a charge from -2 to +1, the method comprising: a) reaction of pertechnetate...  
WO/2010/065899A3
Complexes of heterocyclic radionuclides are prepared based upon ligands having substituted pyridyl and imidazolyl groups. The ligands are bifunctional, having amino acid residues that may act as a linker to a bioactive molecule, and a tr...  
WO/2010/074532A9
The present invention relates to the radioactive marker compound of chemical formula 1 or 2, a composition containing the radioactive marker compound, and a method for preparing the radioactive marker compound. The marker compound of the...  
WO/2010/068051A3
The present invention relates to a process for preparing aromatic iodine compounds. The invention comprises iodination of non-halogenated aromatic compounds, a mono-iodine compound of aromatic compounds, a di-iodine compound of aromatic ...  
WO/2010/074532A3
The present invention relates to the radioactive marker compound of chemical formula 1 or 2, a composition containing the radioactive marker compound, and a method for preparing the radioactive marker compound. The marker compound of the...  
WO/2010/075972A3
The present invention relates to a novel method for producing methyltrioxorhenium (MTO). The present invention further relates to MTO produced according to the method according to the invention, and to the use of MTO as a catalyst.  
WO/2010/010003A3
The invention relates to solutions obtained by reacting at least one Mn-metal complex and at least one aminocarboxylic acid used as a complexing agent, and to the use thereof during the bleaching of cellulose substrates or during the tre...  
WO/2010/075972A2
The present invention relates to a novel method for producing methyl trioxorhenium (MTO). The present invention further relates to MTO produced according to the method according to the invention, and to the use of MTO as a catalyst.  
WO/2010/074532A2
The present invention relates to the radioactive marker compound of chemical formula 1 or 2, a composition containing the radioactive marker compound, and a method for preparing the radioactive marker compound. The marker compound of the...  
WO/2009/140743A3
The invention generally relates to the application of imaging techniques, in particular positron emission tomography (PET) or single photon emission tomography (SPECT), in the assessment of physiological parameters in a subject. The comp...  
WO/2010/068051A2
The present invention relates to a process for preparing aromatic iodine compounds. The invention comprises iodination of non-halogenated aromatic compounds, a mono-iodine compound of aromatic compounds, a di-iodine compound of aromatic ...  
WO/2010/065514A1
A complex containing a transition metal ion and a plurality of donor ligands each of which is fully coordinated to the transition metal ion and is either a nitrogen donor ligand or a cyclometalated donor ligand, such that at least one of...  
WO/2010/065899A2
Complexes of heterocyclic radionuclides are prepared based upon ligands having substituted pyridyl and imidazolyl groups. The ligands are bifunctional, having amino acid residues that may act as a linker to a bioactive molecule, and a tr...  
WO/2010/065906A2
A compound that recognizes and binds to the CA-IX protein has Formula I, II, III, or IV. The compounds may include a radioactive element for radioimaging or therapeutic applications. Thus, pharmaceutical compositions may be prepared with...  
WO/2010/026545A9
Complexes of Manganese ( 11 ) and Cobalt (11) are described, with polyamine ligands, containing carboxylated groups in which the metal atom is coordinated by the nitrogen atoms of the polyamine ligand and by the carboxylated anionic grou...  
WO/2010/057471A1
The present invention relates to chinoxaline compounds, to the use thereof, to an organic semiconductor material, to an organic light-emitting diode, to an organic thin-layer transistor, or to an organic solar cell, and to the use of suc...  
WO/2010/043218A2
The invention relates to a ligand of formula (I), where (CH-R1) and (CH-R1’) are substituted or non-substituted methylene bridges; the individual R1 and R1’, and R3 and R3’, are each selected independently of each other from hydrog...  
WO/2010/036837A1
Processes for direct labeling GSAO and GSAO equivalent compounds with 99mTc(CO)3, radiopharmaceuticals produced by such methods and kits for preparing the direct-labeled radiopharmaceutical compounds.  
WO/2010/036140A1
The invention relates to new metal complexes with the formula M(O)кHmAn-, where M is an isotope of Tc, Re, Sm, Lu, or Y, Н is hydrogen, and А5- is an anion of zoledronic acid, wherein when M is technetium, к=1, m=1, n=2; when M is rh...  
WO/2010/026545A1
Complexes of Manganese ( 11 ) and Cobalt (11) are described, with polyamine ligands, containing carboxylated groups in which the metal atom is coordinated by the nitrogen atoms of the polyamine ligand and by the carboxylated anionic grou...  
WO/2009/112823A3
A method for synthesizing a complex having the formula: [L3MO3]" wherein L3 represents a tridentate ligand, M represents a metal selected from Tc an Re, and n is a charge from -2 to +1, the method comprising: a) reaction of pertechnetate...  

Matches 101 - 150 out of 1,794